Alfuzosin (uroxatral)--another alpha1-blocker for benign prostatic hyperplasia.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000075202:Contraindications; D004347:Drug Interactions; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D011799:Quinazolines / Q000097:blood / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D011799:Quinazolines; C047638:alfuzosin